Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Altitude Acquisition Corp.ALTU · Entity 114367 | Director | September 13, 2022 | September 23, 2022 |
| Astrana Health, Inc.AMEH · Entity 4538 | Director · Co-Chief Executive Officer | November 28, 2018 | December 01, 2018 |
| Cardio Diagnostics Holdings, Inc.CDIO · Entity 8239 | Director | January 23, 2024 | February 21, 2024 |
| General Purpose Acquisition Corp.GPAC · Entity 5958 | Director | December 02, 2025 | December 02, 2025 |
| Nutex Health Inc.NUTX · Entity 4803 | Director · President | March 19, 2026 | March 23, 2026 |
| Veraxa Biotech AGVRXA · Entity 184032 | Director | September 10, 2026 | September 29, 2026 |
| Veraxa Biotech AG - Post de-SPACVRXA · Entity 6310 | Director | June 09, 2026 | June 10, 2026 |
| Voyager Acquisition Corp./Cayman IslandsVACHU · Entity 88278 | Director | August 08, 2024 | August 09, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Altitude Acquisition Corp.
Report date September 13, 2022 · Filed September 23, 2022
This filing explicitly reported no securities owned.
Astrana Health, Inc.
Report date November 28, 2018 · Filed December 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 524,438 |
Reported balance
After 2018-11-28 transaction · row 1
1 source rowRow 1 · 2018-11-28 · Sale · Disposed 35,000 · Balance 524,438 |
Cardio Diagnostics Holdings, Inc.
Report date January 23, 2024 · Filed February 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.11 · Expires 2034-01-23 | Direct | 502,195 |
Reported balance
After 2024-01-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-01-23 · Grant · Acquired 35,719 · Balance 502,195 |
General Purpose Acquisition Corp.
Report date December 02, 2025 · Filed December 02, 2025
This filing explicitly reported no securities owned.
Nutex Health Inc.
Report date March 19, 2026 · Filed March 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,765 |
Reported balance
After 2026-03-19 transaction · row 1
1 source rowRow 1 · 2026-03-19 · Purchase · Acquired 252 · Balance 7,765 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-03-01 | Direct | 12,465 |
Reported balance
After 2026-03-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-10 · Exercise / conversion · Acquired 3,656 · Balance 12,465 F1: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.
Veraxa Biotech AG
Report date September 10, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 634,692 |
Reported balance
After 2026-09-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-10 · Purchase · Acquired 6,024 · Balance 634,692 F1: The reported securities reflect the forfeiture of 71,332 Ordinary Shares of Veraxa Biotech AG (the "Company"), par value CHF 1/113.25, for no additional consideration, in connection with the Company's business combination consummated on June 10, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities reflect the forfeiture of 71,332 Ordinary Shares of Veraxa Biotech AG (the "Company"), par value CHF 1/113.25, for no additional consideration, in connection with the Company's business combination consummated on June 10, 2026.
Veraxa Biotech AG - Post de-SPAC
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 700,000 |
Reported balance
Holding disclosure · report date 2026-06-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 700,000 |
Voyager Acquisition Corp./Cayman Islands
Report date August 08, 2024 · Filed August 09, 2024
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2018 Filed Aug 21, 2018 23:03 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 10,000 | $18.51 | $185,100.00 |
DisclosureSEC source: 0001567619-18-001588 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827,338 Read SEC document |
| June 14, 2018 Filed Jun 15, 2018 22:59 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 20,000 | $16.35 | $327,000.00 |
DisclosureSEC source: 0001140361-18-028864 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837,338 Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 22:59 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 15,000 | $15.77 | $236,550.00 |
DisclosureSEC source: 0001140361-18-028675 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 857,338 Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 22:59 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 13,000 | $15.44 | $200,720.00 |
DisclosureSEC source: 0001140361-18-028675 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 872,338 Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 22:59 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 12,000 | $15.44 | $185,280.00 |
DisclosureSEC source: 0001140361-18-028274 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 885,338 Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 22:59 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 8,000 | $14.73 | $117,840.00 |
DisclosureSEC source: 0001140361-18-028274 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 897,338 Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 23:17 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 14,535 | $14.20 | $206,397.00 |
DisclosureSEC source: 0001140361-18-027943 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 905,338 Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 23:17 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 13,876 | $14.70 | $203,977.20 |
DisclosureSEC source: 0001140361-18-027943 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,873 Read SEC document |
| June 05, 2018 Filed Jun 6, 2018 23:17 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 13,876 | $14.85 | $206,058.60 |
DisclosureSEC source: 0001140361-18-027594 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,749 Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 23:17 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 13,876 | $14.78 | $205,087.28 |
DisclosureSEC source: 0001140361-18-027594 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,625 Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 23:19 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 11,876 | $14.37 | $170,658.12 |
DisclosureSEC source: 0001140361-18-027246 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 961,501 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 23:19 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 9,476 | $13.63 | $129,157.88 |
DisclosureSEC source: 0001140361-18-027246 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 973,377 Read SEC document |
| May 30, 2018 Filed May 31, 2018 23:17 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $13.28 | $78,033.28 |
DisclosureSEC source: 0001140361-18-026669 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982,853 Read SEC document |
| May 29, 2018 Filed May 31, 2018 23:17 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $13.52 | $79,443.52 |
DisclosureSEC source: 0001140361-18-026669 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 988,729 Read SEC document |
| May 25, 2018 Filed May 29, 2018 23:16 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $13.70 | $80,501.20 |
DisclosureSEC source: 0001140361-18-026095 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 994,605 Read SEC document |
| May 24, 2018 Filed May 29, 2018 23:16 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $14.19 | $83,380.44 |
DisclosureSEC source: 0001140361-18-026095 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,481 Read SEC document |
| May 23, 2018 Filed May 24, 2018 17:53 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $14.69 | $86,318.44 |
DisclosureSEC source: 0001140361-18-025484 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,006,357 Read SEC document |
| May 22, 2018 Filed May 24, 2018 17:53 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $15.39 | $90,431.64 |
DisclosureSEC source: 0001140361-18-025484 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,012,233 Read SEC document |
| May 21, 2018 Filed May 22, 2018 23:02 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $15.66 | $92,018.16 |
DisclosureSEC source: 0001140361-18-025250 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,018,109 Read SEC document |
| May 18, 2018 Filed May 22, 2018 23:02 UTC | Astrana Health, Inc. AMEH · Entity 4538 | SaleCommon Stock | 5,876 | $15.90 | $93,428.40 |
DisclosureSEC source: 0001140361-18-025250 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,023,985 Read SEC document |
| February 15, 2018 Filed May 18, 2018 20:35 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 4,953 | $28.90 | $143,141.70 |
DisclosureSEC source: 0001140361-18-024712 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029,861 Read SEC document |
| January 15, 2018 Filed May 18, 2018 23:14 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionStock Option · Derivative | 22,476 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001140361-18-024775 · doc1.xml · derivative · entry 3 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,024 Underlying: Common Stock · 22,476 shares Expires 2021-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2018 Filed May 18, 2018 23:14 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | Tax withholdingCommon Stock | 4,953 | $28.90 | $143,141.70 |
DisclosureSEC source: 0001140361-18-024775 · doc1.xml · nonDerivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029,861 Read SEC document |
| January 15, 2018 Filed May 18, 2018 23:14 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionCommon Stock | 22,476 | $6.37 | $143,172.12 |
DisclosureSEC source: 0001140361-18-024775 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2018 Filed May 18, 2018 20:35 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionStock Option · Derivative | 22,476 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001140361-18-024712 · doc1.xml · derivative · entry 3 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,024 Underlying: Common Stock · 22,476 shares Expires 2021-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2018 Filed May 18, 2018 20:35 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionCommon Stock | 22,476 | $6.37 | $143,172.12 |
DisclosureSEC source: 0001140361-18-024712 · doc1.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,034,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 18:11 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 23,363 | $0.00 Strike: $10.18 | $0.00 |
DisclosureSEC source: 0001498865-17-000008 · primary_doc.xml · derivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,363 Underlying: Common Stock · 23,363 shares Expires 2022-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| April 06, 2017 Filed Apr 10, 2017 18:11 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 6,637 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001498865-17-000008 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,637 Underlying: Common Stock · 6,637 shares Expires 2027-04-05 F1 · derivative.exercise_date: The option is exercisable at the rate of 1/24th of the shares each month commencing May 6, 2017. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:20 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 93,500 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001498865-16-000005 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · shares: The option vested as to two-thirds of the shares on February 15, 2016 and the balance vests at the rate of one-twelfth per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Apr 10, 2017 18:38 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 93,500 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001498865-17-000010 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires 2021-02-14 F1 · derivative.expiration_date: The purpose of this amendment is to correct the expiration date of the option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.